LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks
Authors:
- R N JonesRJR N Jones
- C BakerCBC Baker
- A L BarryABA L Barry
- P C FuchsPFP C Fuchs
Open Access
- 1 March 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 29 (3) , 530-534
Abstract
A new oral cephalosporin, LY164846 (Eli Lilly & Co., Indianapolis, Ind.), was found to have a unique antimicrobial spectrum confined to methicillin-susceptible Staphylococcus spp., streptococci (except Enterococcus spp.), Haemophilus influenzae, Branhamella catarrhalis, and some anaerobes. Cephalothin in vitro tests (30-microgram disks or dilution) can represent LY164846 for laboratory testing if comparable interpretive breakpoints are applied to strains within the spectrum of LY164846. Organisms not inhibited by LY164846 (MICs greater than or equal to 32 micrograms/ml) were members of the family Enterobacteriaceae, Pseudomonas spp., Acinetobacter spp., enterococci, and some strains of Staphylococcus haemolyticus and of the Bacteroides fragilis group.Keywords
This publication has 6 references indexed in Scilit:
- In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibioticAntimicrobial Agents and Chemotherapy, 1984
- Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testingJournal of Clinical Microbiology, 1983
- The antimicrobial activity of cephalexin against old and new pathogens.1983
- Summary of laboratory studies on the antibacterial activity of cefaclor.1979
- Cefadroxil, a New Broad-Spectrum CephalosporinAntimicrobial Agents and Chemotherapy, 1977
- Susceptibility Tests of Anaerobic Bacteria: Statistical and Clinical ConsiderationsThe Journal of Infectious Diseases, 1974